Advocating for Impact: Empowering Pharmacists to Treat Opioid Use Disorder

ASHPOfficial · Apr 4, 2023 · 23m

Prior to 2023, the “X-waiver” requirement prohibited pharmacists from prescribing buprenorphine as treatment for opioid use disorder (OUD). Now that the X-waiver has been eliminated, pharmacists now have more flexibility to engage in team-based OUD treatment via collaborative practice. This podcast will explore potential practice models relating to pharmacist-provided OUD treatment, review current laws and limitations on pharmacists engaging in controlled substance prescribing, and discuss advocacy initiatives to enhance pharmacists’ role as treatment providers.

The information presented…